Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 15, 2025 • 6:00 AM ET

Date/Time Source News Release
05/29/2025 07:01 AM EDT Business Wire Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
05/14/2025 09:00 PM EDT GlobeNewswire Bragar Eagel & Squire, P.C. Is Investigating Organon, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the Firm
05/07/2025 09:00 PM EDT GlobeNewswire Bragar Eagel & Squire, P.C. Is Investigating RobinHood, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the Firm
05/07/2025 08:46 AM EDT GlobeNewswire ALDX SECURITIES UPDATE: Aldeyra Therapeutics Investors with Losses may have been affected by Securities Violations - Contact BFA Law (NASDAQ:ALDX)
05/06/2025 04:42 PM EDT GlobeNewswire Aldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter - Hagens Berman
05/06/2025 07:08 AM EDT Newsfile ALDX SECURITIES INVESTIGATION: Aldeyra Therapeutics Investors are Notified to Contact BFA Law about Pending Securities Investigation
05/05/2025 06:34 PM EDT Business Wire Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission
05/05/2025 04:00 PM EDT Business Wire Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Topline Results from Phase 3 Dry Eye Disease Clinical Trials of Reproxalap
05/04/2025 08:18 AM EDT Newsfile ALDX INQUIRY: BFA Law Notifies Aldeyra Therapeutics, Inc. Investors to Contact the Firm About Pending Investigation into the Company
05/01/2025 04:18 PM EDT GlobeNewswire Aldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter - Hagens Berman
Page

Additional News

As of June 15, 2025 • 6:00 AM ET

Date/Time Source News Release
05/29/2025 09:08 AM EDT Stock Traders Daily Trading (ALDX) With Integrated Risk Controls
05/15/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 15th, 2025
05/15/2025 05:30 AM EDT US Earnings Reports Expected earnings - Aldeyra Therapeutics Inc.
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Aldeyra Therapeutics Inc.
05/06/2025 03:48 PM EDT ACCESS Newswire IA ALDX SECURITIES NEWS: Aldeyra Therapeutics, Inc. Investigation Could Allow Investors to Recover Losses; Contact BFA Law to Discuss
05/01/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 1st, 2025
05/01/2025 05:30 AM EDT US Earnings Reports Expected earnings - Aldeyra Therapeutics Inc.
04/30/2025 03:38 PM EDT ACCESS Newswire IA ALDX ANNOUNCEMENT: Aldeyra Therapeutics, Inc. Investors may have been affected by Securities Violations - Contact BFA Law
04/29/2025 04:07 PM EDT ACCESS Newswire IA ALDX NEWS: Aldeyra Therapeutics, Inc. is Being Investigated for Securities Violations - Investors are Alerted to Contact BFA Law
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.